View in EDS

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.

Saved in:
Bibliographic Details
Title: Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.
Authors: Schwarz M; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Schwarz C; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Schütz A; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Schwanke C; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Krabb E; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Schubert R; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Liebich ST; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Bauer D; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Burghart L; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Brinkmann L; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Gutic E; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria., Reiberger T; Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Vienna, Austria.; Vienna HIV & Liver Study Group, Vienna, Austria., Haltmayer H; Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria., Gschwantler M; Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria.; Sigmund Freud University, Vienna, Austria.
Source: Journal of virus eradication [J Virus Erad] 2023 Mar 02; Vol. 9 (1), pp. 100319. Date of Electronic Publication: 2023 Mar 02 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101654142 Publication Model: eCollection Cited Medium: Print ISSN: 2055-6640 (Print) Linking ISSN: 20556640 NLM ISO Abbreviation: J Virus Erad Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2055-6640
DOI:10.1016/j.jve.2023.100319